AVI-6002

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAVI-6002
Drug Alias NameAVI-7539/AVI-7357AVI 60026002AVI-7357/AVI-7539
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionPolymerase cofactor VP35 modulatorsViral RNA inhibitors
TargetsPolymerase cofactor VP35Viral RNA
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSarepta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSarepta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A